Asthma and COPD are the 5th and 6th most costly conditions in the United States today estimated at over $70 billion annually. By helping patients improve their asthma control and COPD status, you can reduce the cost of treating these respiratory illnesses by eliminating avoidable hospitalizations and ER visits due to respiratory exacerbations.
26% of COPD patients admitted to the hospital will be readmitted within the next 12 months. Effective 2015, CMS expanded their rules to include COPD for all cause readmissions. Conversio Health can assist you by partnering with your ACO to reduce readmissions for patients with chronic respiratory conditions at no cost to the ACO!
Conversio Health partners with ACOs to integrate our unique pharmacy-based model of care and care coordination services for patients with chronic respiratory conditions. Our solution does not replace your ACO’s care coordination programs, but rather, serves to compliment them by integrating closely with your care managers. Our program has been proven to improve patient compliance resulting in an improved quality of care, reduced costs and increased HEDIS/STARS measurement values.